1.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.17
Aprire:
$1.1714
Volume 24 ore:
71,266
Relative Volume:
0.92
Capitalizzazione di mercato:
$12.10M
Reddito:
$3,000
Utile/perdita netta:
$-8.79M
Rapporto P/E:
-0.542
EPS:
-2.1033
Flusso di cassa netto:
$-8.46M
1 W Prestazione:
-8.80%
1M Prestazione:
-17.99%
6M Prestazione:
-38.71%
1 anno Prestazione:
-58.09%
Biocardia Inc Stock (BCDA) Company Profile
Nome
Biocardia Inc
Settore
Industria
Telefono
650-226-0123
Indirizzo
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA vs SHMD, GOODO, PSNYW, DWLD, QQQE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
|
SHMD
Schmid Group N V
|
7.55 | 483.19M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.30 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
3.00 | 268.25M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DWLD
Davis Select Worldwide ETF
|
46.10 | 0 | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
102.68 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-04-16 | Downgrade | Dawson James | Buy → Neutral |
Biocardia Inc Borsa (BCDA) Ultime notizie
BioCardia submits FDA pre-submission for heart delivery catheter By Investing.com - Investing.com Nigeria
Biocardia files pre-submission for FDA approval of Helix(TM) - marketscreener.com
BioCardia (BCDA) Advances Helix Catheter Approval with FDA Pre-S - GuruFocus
BioCardia submits FDA pre-submission for heart delivery catheter - Investing.com
BioCardia Advances FDA Pathway for Helix Delivery Catheter - TipRanks
BioCardia Submits Pre-Submission to FDA for Helix Transendocardial Delivery Catheter Approval - Quiver Quantitative
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart - marketscreener.com
BioCardia Files Pre-Submission for FDA Approval of Helix™ - GlobeNewswire
Insider Buying: Peter Altman Acquires Additional Shares of BioCa - GuruFocus
BioCardia’s CardiAMP Heart Failure Data Selected for LBCT - TipRanks
BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT) - The Manila Times
BioCardia, Inc. Announces Presentation of CardiAMP HF Trial Data - TradingView
Heart failure cell therapy trial lands late-breaking THT slot for echo data - stocktitan.net
Insider Sell: Will Matador Resources Company benefit from geopolitical trendsDividend Hike & Weekly Momentum Stock Picks - baoquankhu1.vn
Activity Recap: Does BioCardia Inc have consistent dividend growthQuarterly Trade Review & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug Ideas: Whats Sono Tek Corporations historical returnPortfolio Value Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Chipmakers Recap: Should you avoid BioCardia Inc stock right now2025 Earnings Impact & Safe Swing Trade Setup Alerts - baoquankhu1.vn
IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36% - Intellectia AI
Altman Peter buys BioCardia (BCDA) shares worth $1,194 By Investing.com - Investing.com Nigeria
Altman Peter buys BioCardia (BCDA) shares worth $1,194 - Investing.com
Trend Review: Is BioCardia Inc. in a long term uptrendWeekly Investment Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
US Stocks Recap: Can BioCardia Inc expand its profit marginsJuly 2025 Big Picture & Weekly Chart Analysis and Guides - baoquankhu1.vn
Swing Trade: Is BioCardia Inc stock forming a triangle patternGap Up & High Accuracy Trade Alerts - baoquankhu1.vn
Can BioCardia Inc. stock deliver surprise earnings beat2025 Buyback Activity & AI Enhanced Trade Execution Alerts - Bộ Nội Vụ
Published on: 2026-01-10 18:46:33 - Улправда
Will BioCardia Inc. (6JU0) stock keep high P E multiplesPortfolio Return Report & Reliable Entry Point Alerts - Улправда
Can BioCardia Inc. stock continue upward trendWeekly Stock Report & AI Optimized Trading Strategy Guides - Улправда
Forecast Cut: Will BioCardia Inc. stock rally after Fed decisionsJuly 2025 Weekly Recap & Daily Entry Point Alerts - ulpravda.ru
Will BioCardia Inc. stock rally after Fed decisionsMarket Activity Report & Community Trade Idea Sharing Platform - Улправда
How BioCardia Inc. stock reacts to bond yields2026 world cup usa national team qualification midfield engines set piece tactics expert forecast analysis - Улправда
Bull Run: Why analysts raise outlook for BioCardia Inc 6JU0 stock2025 Market Outlook & Daily Profit Focused Stock Screening - moha.gov.vn
Profit Review: Will BioCardia Inc 6JU0 stock sustain uptrend momentumJuly 2025 Volume & Safe Capital Growth Stock Tips - moha.gov.vn
Is BioCardia Inc 6JU0 a good long term investmentEconomic Indicators Overview & Free Stay Ahead With Picks - earlytimes.in
BioCardia (BCDA) Stock Analysis Report | Financials & Insights - Benzinga
BioCardia advances CardiAMP therapy in Japan - MSN
Will BioCardia Inc. stock deliver long term returns2025 Technical Patterns & Daily Growth Stock Tips - Улправда
Will BioCardia Inc. stock keep outperforming rivals2025 Winners & Losers & Weekly Top Performers Watchlists - Улправда
Why BioCardia Inc. stock remains on buy lists2025 Winners & Losers & Consistent Income Trade Ideas - Улправда
Is BioCardia Inc. (6JU0) stock prepared for digital transitionTake Profit & Fast Exit Strategy with Risk Control - Улправда
Why retail investors pile into BioCardia Inc. stock2025 Volume Leaders & Reliable Volume Spike Trade Alerts - Улправда
Why BioCardia Inc. (6JU0) stock is trending on social media2025 Technical Patterns & Technical Entry and Exit Tips - Улправда
Is BioCardia Inc. (6JU0) stock protected from inflationJuly 2025 Earnings & Precise Swing Trade Alerts - Улправда
Is BioCardia Inc. stock attractive for ETFsMarket Performance Recap & Daily Price Action Insights - Улправда
BioCardia (BCDA) registers 424,509 incentive plan shares after 2025 vote - Stock Titan
Meme Stocks: Will BioCardia Inc. stock deliver long term returnsJuly 2025 EndofMonth & Verified Entry Point Signals - Улправда
BioCardia first patient enrolled at Henry Ford Health for Phase 3 CardiAMP - MSN
CEO Altman Buys 1,100 ($1.4K) Of BioCardia Inc [BCDA] - TradingView — Track All Markets
BioCardia (BCDA) CEO and president discloses December insider share buys - Stock Titan
BioCardia (BCDA) Advances CardiAMP Therapy for Heart Failure in Japan - GuruFocus
Biocardia cell therapy to enter PMDA clinical consultation - marketscreener.com
BioCardia Advances CardiAMP Therapy in Japan - TipRanks
Biocardia Inc Azioni (BCDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biocardia Inc Azioni (BCDA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Altman Peter | President and CEO |
Jan 20 '26 |
Buy |
1.32 |
600 |
792 |
268,566 |
| Altman Peter | President and CEO |
Jan 21 '26 |
Buy |
1.34 |
300 |
402 |
268,866 |
| Altman Peter | President and CEO |
Dec 17 '25 |
Buy |
1.30 |
900 |
1,170 |
267,966 |
| Altman Peter | President and CEO |
Dec 16 '25 |
Buy |
1.37 |
200 |
274 |
267,066 |
| STERTZER SIMON H | Director |
Sep 19 '25 |
Buy |
1.25 |
398,400 |
498,000 |
591,054 |
| Blank Andrew Scott | Director |
Sep 19 '25 |
Buy |
1.25 |
288,000 |
360,000 |
634,023 |
| Altman Peter | President and CEO |
Sep 19 '25 |
Buy |
1.25 |
48,000 |
60,000 |
216,762 |
| Altman Peter | President and CEO |
Aug 22 '25 |
Buy |
1.83 |
700 |
1,281 |
168,762 |
| Altman Peter | President and CEO |
Aug 13 '25 |
Buy |
1.83 |
100 |
183 |
168,062 |
| Altman Peter | President and CEO |
Aug 12 '25 |
Buy |
1.75 |
400 |
700 |
167,962 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):